Abstract
Acne vulgaris is the most common disease involving the pilosebaceous unit. It is rarely misdiagnosed. It occurs at the site where there are sebaceous follicles and thus occurs predominantly on the face, back and chest. It occurs in all races and affects both sexes. The onset of acne is usually in early adolescence and affects up to 80% of all individuals. The milder physiological acne, which affects many adolescents, will last for 4 or 5 years, but the more clinical varieties will last for 12, and sometimes even 40 or 50 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Further reading
Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris. Dermatology 1993; 187: 193–6.
Chalker DK, Lesher JL, Smith JG et al Efficacy of topical isotretinoin 0.05% gel in acne vulgaris. Results of a multicenter, double-blind investigation. J Am Acad Dermatol 1987; 17: 251–4.
Cunliffe WJ, Clayden AD, Gould D et al Acne vulgaris—its aetiology and treatment. Rev Clin Exp Dermatol 1981; 6: 461–9.
Cunliffe WJ, Van der Kerkhof PCM, Caputo R et al Roaccutane treatment guidelines, results of an international survey. Dermatology 1994; 351–7.
Eady EA, Jones CE, Tipper, JL, Cove JH, Cunliffe, WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. Br Med J 1993; 306: 555–6.
Goulden V, Glass D, Cunliffe WJ. Safety of long term high dose minocycline in the treatment of acne. Br J Dermatol 1996; 134: 693–5.
Goulden V, Layton AM, Cunliffe WJ. Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology 1995; 190: 284–7.
Hammerstein J, Cupceancu B. Behandlung des Hirsutismus mit Cyproteronacetat. Dtsch Med Wochenschr 1969; 94: 829–34.
Katsambas A. Why and when the treatment of acne fails. What to do. Dermatology 1998; 196: 158–61.
Lyons RE. Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris. lot Dermatol 1978; 17: 246–51.
Ross JI, Carnegie E, Snelling AM et al Prevalence of antibiotic resistant propionibacteria on the skin of acne patients from six European countries. JEADV 2001; 15 (Suppl. 2): 135.
Schaefer H. Penetration and percutaneous absorption of topical retinoids. Rev Skin Pharmacol 1993; 6: 17–23.
Seukeran DC, Eady AE, Cunliffe WJ. Benefit-risk assessment of acne therapies. Lancet 1997; 349: 1251.
Shalita A, Weiss JS, Chalker DK et al A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996; 34: 482–5.
Strauss JS, Rapini RP, Shalita AR et al Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984; 10: 490–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cunliffe, W.J. (2003). Acne. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-07131-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05657-4
Online ISBN: 978-3-662-07131-1
eBook Packages: Springer Book Archive